Thursday 27 January 2022
Home      All news      Contact us      RSS      India
dailyexcelsior.com - 13 days ago

Aurobindo Pharma gets warning letter from USFDA for API facility

New Delhi, Jan 14: Aurobindo Pharma on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API (active pharmaceutical ingredient) manufacturing facility. The action follows the recent inspection of the facility by the US Food and Drug Administration (USFDA) in August 2021, the drugmaker said in a regulatory filing. The company believes that this will not impact the existing business from this facility, it noted. The drugmaker stated that it [ ] The post Aurobindo Pharma gets warning letter from USFDA for API facility appeared first on Jammu Kashmir Latest News | Tourism | Breaking News J K.


Latest News
Hashtags:   

Aurobindo

 | 

Pharma

 | 

warning

 | 

letter

 | 

USFDA

 | 

facility

 | 

Sources